Sachs L, Lotem J
Department of Molecular Genetics and Virology, Weizmann Institute of Science, Rehovot, Israel.
Proc Soc Exp Biol Med. 1994 Jul;206(3):170-5. doi: 10.3181/00379727-206-43736.
Cell viability, multiplication, and differentiation to the various hematopoietic cell lineages are induced by a multigene cytokine family, and hematopoiesis is controlled by a network of interactions between these cytokines. This network includes positive regulators such as colony-stimulating factors and interleukins, and negative regulators such as transforming growth factor-beta and tumor necrosis factor. The functioning of the network requires an appropriate balance between positive and negative regulators, and the selective regulation of programmed cell death (apoptosis) by interaction of cytokines with their receptors. The cytokine network, which has arisen during evolution, allows considerable flexibility, depending on which part of the network is activated, and the ready amplification of response to a particular stimulus. This amplification occurs by autoregulation and transregulation of genes for the hematopoietic cytokines. There is also a transregulation by these cytokines of cytokine receptors. In addition to the flexibility of this network, both for response to present day infections and to infections that may develop in the future, a network may also be necessary to stabilize the whole system. The existence of a network and the cytokine-receptor regulation of apoptosis has to be taken into account in the clinical use of cytokines for therapy. Cytokines that regulate hematopoiesis induce the expression of genes for transcription factors. Cytokine signaling through transcription factors can thus ensure the autoregulation and transregulation of cytokine and receptor genes that occur in the network. Interactions between the cytokine network and transcription factors can also ensure production of specific cell types and stability of the differentiated state.
细胞活力、增殖以及向各种造血细胞谱系的分化是由一个多基因细胞因子家族诱导的,造血作用受这些细胞因子之间相互作用网络的控制。该网络包括集落刺激因子和白细胞介素等正调节因子,以及转化生长因子-β和肿瘤坏死因子等负调节因子。网络的运作需要正、负调节因子之间保持适当平衡,以及细胞因子与其受体相互作用对程序性细胞死亡(凋亡)进行选择性调节。在进化过程中出现的细胞因子网络具有相当大的灵活性,这取决于网络的哪一部分被激活,以及对特定刺激的反应能迅速放大。这种放大通过造血细胞因子基因的自动调节和转调节来实现。这些细胞因子对细胞因子受体也存在转调节作用。除了该网络在应对当今感染和未来可能发生的感染方面具有灵活性外,可能还需要一个网络来稳定整个系统。在临床使用细胞因子进行治疗时,必须考虑到网络的存在以及细胞因子 - 受体对凋亡的调节。调节造血作用的细胞因子可诱导转录因子基因的表达。通过转录因子进行的细胞因子信号传导因此可以确保网络中发生的细胞因子和受体基因的自动调节和转调节。细胞因子网络与转录因子之间的相互作用还可以确保特定细胞类型的产生以及分化状态的稳定性。